Skip to content
Oxford Vacmedix
  • Home
  • About
    • What We Do
    • Partnering Outlook
    • Our Team
  • Technology
    • Technology
    • Recombinant Overlapping Peptide
    • T Cell Receptor
  • Pipeline
  • News
  • Contact

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

Publications / 31st May 2018 27th July 2018

Melief CJ, van der Burg SH.  Nat Rev Cancer. 2008 May;8(5):351-60.

Post navigation

← Previous Post
Next Post →

About Us

Our aim is to develop therapeutic agents for the treatment of cancer based on the invention of Dr Shisong Jiang – Recombinant Overlapping Peptides (ROP).

FIND OUT MORE

Useful Links

  • Contact Us
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy

Main menu

  • Home
  • About
  • Technology
  • News
  • Contact
Copyright © 2020 Oxford Vacmedix | Website development by FDM Digital